{"id":"https://openalex.org/W2582680340","doi":"https://doi.org/10.1128/aac.02068-16","title":"Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis","display_name":"Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis","alternate_titles":[],"publication_year":2017,"publication_date":"2017-01-30","ids":{"openalex":"https://openalex.org/W2582680340","doi":"https://doi.org/10.1128/aac.02068-16","mag":"2582680340","pmid":"https://pubmed.ncbi.nlm.nih.gov/28137806","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5365645"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02068-16","doi":"https://doi.org/10.1128/aac.02068-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02068-16","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2582680340"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1128/aac.02068-16","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072724821","display_name":"Stephen A. Wring","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen A. Wring","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002914687","display_name":"Ryan Randolph","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Randolph","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101399886","display_name":"Seonghee Park","orcid":"https://orcid.org/0000-0003-2902-8341","observed_orcids":["https://orcid.org/0000-0003-2902-8341"]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SeongHee Park","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091470367","display_name":"George K. Abruzzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Abruzzo","raw_affiliation_strings":["Merck & Co., Inc., Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119532430","display_name":"Qing Chen","orcid":"https://orcid.org/0000-0002-8450-9300","observed_orcids":["https://orcid.org/0000-0002-8450-9300"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing Chen","raw_affiliation_strings":["Merck & Co., Inc., Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068696483","display_name":"Amy M. Flattery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Flattery","raw_affiliation_strings":["Merck & Co., Inc., Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037248620","display_name":"Graigory C. Garrett","orcid":"https://orcid.org/0009-0008-4181-2677","observed_orcids":["https://orcid.org/0009-0008-4181-2677"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Graig Garrett","raw_affiliation_strings":["Merck & Co., Inc., Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065456947","display_name":"Michael R. Peel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Peel","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010072595","display_name":"Russell J. Outcalt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell Outcalt","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023989112","display_name":"Kendall D. Powell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kendall Powell","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069236002","display_name":"Michelle Trucksis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Trucksis","raw_affiliation_strings":["Merck & Co., Inc., Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103919484","display_name":"David A Angulo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Angulo","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010901896","display_name":"Katyna Borroto\u2013Esoda","orcid":"https://orcid.org/0000-0002-3909-6578","observed_orcids":["https://orcid.org/0000-0002-3909-6578"]},"institutions":[{"id":"https://openalex.org/I4210144816","display_name":"Scynexis (United States)","ror":"https://ror.org/03drnt809","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katyna Borroto-Esoda","raw_affiliation_strings":["SCYNEXIS, Inc., Jersey City, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc., Jersey City, New Jersey, USA","institution_ids":["https://openalex.org/I4210144816"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072724821"],"corresponding_institution_ids":["https://openalex.org/I4210144816"],"apc_list":null,"apc_paid":null,"fwci":7.8729,"has_fulltext":true,"cited_by_count":101,"citation_normalized_percentile":{"value":0.98324895,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"61","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10497","display_name":"Fungal and yeast genetics research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-candidiasis","display_name":"systemic candidiasis","score":0.906000018119812},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9549999833106995},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7549999952316284},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.5339999794960022},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.7599999904632568},{"id":"https://openalex.org/keywords/auc-mic","display_name":"AUC/MIC","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cmax-mic","display_name":"Cmax/MIC","score":0.8629999756813049},{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.5559999942779541},{"id":"https://openalex.org/keywords/mouse-model-of-infection","display_name":"mouse infection model","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.854860782623291},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6655324101448059},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.609096884727478},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.5416245460510254},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.49738577008247375},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.46799108386039734},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4419700503349304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4027811288833618},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33299127221107483},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002473","descriptor_name":"Cell Wall","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002473","descriptor_name":"Cell Wall","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005936","descriptor_name":"Glucans","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D005936","descriptor_name":"Glucans","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010616","descriptor_name":"Phenanthrenes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010616","descriptor_name":"Phenanthrenes","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010616","descriptor_name":"Phenanthrenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054796","descriptor_name":"Drug Dosage Calculations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.02068-16","doi":"https://doi.org/10.1128/aac.02068-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02068-16","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5365645","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5365645/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5365645/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:28137806","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28137806","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1128/aac.02068-16","doi":"https://doi.org/10.1128/aac.02068-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02068-16","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2582680340.pdf","grobid_xml":"https://content.openalex.org/works/W2582680340.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W152943885","https://openalex.org/W1502213987","https://openalex.org/W1851907565","https://openalex.org/W1978399068","https://openalex.org/W1979356733","https://openalex.org/W2016292914","https://openalex.org/W2032321007","https://openalex.org/W2064799851","https://openalex.org/W2065891345","https://openalex.org/W2084375116","https://openalex.org/W2086009689","https://openalex.org/W2089162191","https://openalex.org/W2099312423","https://openalex.org/W2099951777","https://openalex.org/W2100354457","https://openalex.org/W2114874905","https://openalex.org/W2122363207","https://openalex.org/W2123787514","https://openalex.org/W2128930731","https://openalex.org/W2136148468","https://openalex.org/W2143849345","https://openalex.org/W2144465276","https://openalex.org/W2146555604","https://openalex.org/W2146907515","https://openalex.org/W2147335917","https://openalex.org/W2147556278","https://openalex.org/W2149555509","https://openalex.org/W2151225364","https://openalex.org/W2152606779","https://openalex.org/W2158070953","https://openalex.org/W2163949202","https://openalex.org/W2164848236","https://openalex.org/W2216117396","https://openalex.org/W2260819425","https://openalex.org/W2480520968"],"related_works":["https://openalex.org/W2143849345","https://openalex.org/W2753997246","https://openalex.org/W2568587140","https://openalex.org/W2586701728","https://openalex.org/W2902361714","https://openalex.org/W2617660350","https://openalex.org/W2756180633","https://openalex.org/W2770721343","https://openalex.org/W2804930666","https://openalex.org/W2773484769"],"abstract_inverted_index":{"ABSTRACT":[0],"SCY-078":[1,21,45,147,186,249],"(MK-3118)":[2],"is":[3,46],"a":[4,138,151,272],"novel,":[5],"semisynthetic":[6],"derivative":[7],"of":[8,15,19,25,35,56,74,103,128,141,146,197,229,264],"enfumafungin":[9],"and":[10,42,69,95,101,119,182,206,253,258,275],"represents":[11],"the":[12,16,54,168,171,216,234,251],"first":[13],"compound":[14],"triterpene":[17],"class":[18],"antifungals.":[20],"exhibits":[22],"potent":[23],"inhibition":[24],"\u03b2-(1,3)-":[26],"d":[27],"-glucan":[28],"synthesis,":[29],"an":[30,226],"essential":[31],"cell":[32],"wall":[33],"component":[34],"many":[36],"pathogenic":[37],"fungi,":[38],"including":[39],"Candida":[40],"spp.":[41,44],"Aspergillus":[43],"currently":[47],"in":[48,93,117,124,148,260],"phase":[49],"2":[50],"clinical":[51],"development":[52],"for":[53,154,167,238,278],"treatment":[55,277],"invasive":[57,155,279],"fungal":[58,156,280],"diseases.":[59,281],"In":[60],"vitro":[61],"disposition":[62],"studies":[63,80],"to":[64,86,114,135,165,177,267],"assess":[65],"solubility,":[66],"intestinal":[67],"permeability,":[68],"metabolic":[70],"stability":[71],"were":[72,81],"predictive":[73],"good":[75],"oral":[76,191,252,276],"bioavailability.":[77],"Preclinical":[78],"pharmacokinetic":[79,256],"consistent":[82],"with":[83,209,225],"once-daily":[84],"administration":[85],"humans.":[87],"After":[88],"intravenous":[89,254],"delivery,":[90],"plasma":[91,162,217],"clearance":[92],"rodents":[94],"dogs":[96],"was":[97,112,121,132,221,242],"low,":[98],"representing":[99],"<15%":[100],"<25%":[102],"hepatic":[104],"blood":[105],"flow,":[106],"respectively.":[107],"The":[108,126,200],"terminal":[109],"elimination-phase":[110],"half-life":[111],"5.5":[113],"8.7":[115],"h":[116,123,176],"rodents,":[118],"it":[120],"\u223c9.3":[122],"dogs.":[125],"volume":[127],"distribution":[129],"at":[130],"steady-state":[131],"high":[133],"(4.7":[134],"5.3":[136],"liters/kg),":[137],"finding":[139],"suggestive":[140],"extensive":[142],"tissue":[143],"distribution.":[144],"Exposure":[145],"kidney":[149],"tissue,":[150],"target":[152],"organ":[153],"disease":[157],"such":[158],"as":[159,215,271],"candidiasis,":[160],"exceeded":[161],"by":[163],"20-":[164],"25-fold":[166],"area":[169],"under":[170],"concentration-time":[172],"curve":[173],"from":[174],"0":[175],"infinity":[178],"(AUC":[179],"0\u2013\u221e":[180],")":[181],"C":[183,203],"max":[184,204],".":[185],"achieved":[187],"efficacy":[188],"endpoints":[189],"following":[190],"delivery":[192],"across":[193,223],"multiple":[194],"murine":[195,261],"models":[196,263],"disseminated":[198,265],"candidiasis.":[199],"pharmacokinetic/pharmacodynamic":[201],"indices":[202],"/MIC":[205],"AUC/MIC":[207,241],"correlated":[208],"outcome.":[210],"Target":[211],"therapeutic":[212],"exposure,":[213],"expressed":[214],"AUC":[218],"0\u201324":[219],",":[220],"comparable":[222],"models,":[224],"upper":[227],"value":[228,237],"11.2":[230],"\u03bcg\u00b7h/ml":[231],"(15.4":[232],"\u03bcM\u00b7h);":[233],"corresponding":[235],"mean":[236],"free":[239],"drug":[240],"\u223c0.75.":[243],"Overall,":[244],"these":[245],"results":[246],"demonstrate":[247],"that":[248],"has":[250],"(i.v.)":[255],"properties":[257],"potency":[259],"infection":[262],"candidiasis":[266],"support":[268],"further":[269],"investigation":[270],"novel":[273],"i.v.":[274]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2582680340","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-02-03T00:00:00"}
